Home > Cashflow Statement > GLAND PHARMA

GLAND PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-433 Cr₹-799 Cr₹15 Cr₹35 Cr₹1,238 Cr

What is the latest Cash Flow from Financing Activities ratio of GLAND PHARMA ?

The latest Cash Flow from Financing Activities ratio of GLAND PHARMA is ₹-433 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-433 Cr
Mar2024₹-799 Cr
Mar2023₹15 Cr
Mar2022₹35 Cr
Mar2021₹1,238 Cr

How is Cash Flow from Financing Activities of GLAND PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-433 Cr
Negative
Mar2024 ₹-799 Cr
Negative
Mar2023 ₹15 Cr
-57.25
Mar2022 ₹35 Cr
-97.18
Mar2021 ₹1,238 Cr -

Compare Cash Flow from Financing Activities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹41,495.0 Cr 5.7% 2.1% 24.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹480,047.0 Cr 3.1% 7.2% 18.3% Stock Analytics
DIVIS LABORATORIES ₹208,141.0 Cr 8.2% 19.8% 17.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,264.0 Cr -1.8% 4.9% 37.2% Stock Analytics
CIPLA ₹118,430.0 Cr 3.9% 0.6% 0% Stock Analytics
DR REDDYS LABORATORIES ₹95,516.1 Cr -0.7% -14.6% -8.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

5.7%

2.1%

24.8%

SENSEX

2%

1.9%

-5.2%


You may also like the below Video Courses